Movicol Paediatric Plain Sachet (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350)

The macrogol 3350 component acts as an osmotic agent that draws water into the intestinal lumen. The added electrolytes help maintain fluid balance while the increased water softens the stool, promoting regular bowel movements without stimulating intestinal secretions directly.

The appropriate dose of Movicol Paediatric Plain Sachet is determined by the prescribing clinician based on the child’s age, weight, severity of constipation, and overall health status. Dosage instructions are provided on the prescription label and should be followed exactly as directed by the healthcare professional.

Safety data for macrogol‑based laxatives in pregnancy and lactation are limited. The product should only be used during pregnancy or breastfeeding if the prescriber judges that the potential benefit outweighs any possible risk to the mother or infant. Consultation with a healthcare provider is essential before use.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with stimulant laxatives, macrogol‑based products like Movicol provide a gentler, osmotic mechanism that softens stool without causing cramping. They are generally preferred for long‑term management of constipation in children because they have a lower incidence of abdominal pain and are well tolerated when used as directed.

Store at room temperature: keep the sachets in their original packaging, protect them from moisture and excessive heat. Do not store in a refrigerator or freezer, and ensure the product is kept out of reach of children.

The sachet is intended for oral use. The contents are typically dissolved in a measured amount of water, milk or juice, stirred until fully dissolved, and then given to the child to drink. Administration should follow the instructions provided by the prescribing clinician.

Serious risks include severe abdominal pain, significant electrolyte disturbances (such as hypernatremia or hyperkalaemia), and rare allergic reactions that may present as rash, swelling or breathing difficulty. Prompt medical attention is required if any of these symptoms occur.

Children with known hypersensitivity to macrogol, any of the electrolytes, or other components of the formulation should avoid the product. It is also contraindicated in cases of intestinal obstruction, perforation, or severe renal impairment unless specifically directed by a specialist.